Mirae Asset Global Etfs Holdings Ltd. Cue Biopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,897 shares of CUE stock, worth $10,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,897Holding current value
$10,201% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CUE
# of Institutions
77Shares Held
13.8MCall Options Held
56.1KPut Options Held
11.1K-
Bleichroeder LP New York, NY2.86MShares$1.63 Million1.28% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$1.37 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$1.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$431,3390.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny494KShares$281,5720.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $20.2M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...